Screening, enrollment, PK study, and one-year follow-up to assess drug efficacy.</p
Occurrence of the main study outcomes and mean follow-up time according to cohort and effectiveness ...
Quantitative sum of number of studies investigating reliability and validity of screening tools.</p
Number of studies found after the visits and initial key word search and after the first screening o...
Overview of number of patients that underwent initial and follow-up screening per year.</p
<p>Enrollment, attrition, drug treatments, and outcomes of patients in all samples.</p
<p>Flowchart of included efficacy trials and additional reports of long-term follow-up assessments.<...
<p>Enrollment, randomization, follow-up, and inclusion in the final analysis in the study comparing ...
Completion status of vaccine series based on year of incident prescription, and number and proportio...
<p>Treatments administered by each study and respective study characteristics for included efficacy ...
Follow-up periods and required doses applied per vaccine for series completion.</p
PrEP uptake and persistence at baseline, 6 months, and 12 months after study enrollment.</p
<p>Cohort enrolment, treatment and follow up and decision making for progression to screening of the...
Analysis of the effects of the interventions on uptake of VMMC three months after enrollment.</p
<p>Description of follow-up time in years for study patients on anti-retroviral therapy (n = 1,282)....
<p>Prescribed amount and number of years of prescription of fall-risk-increasing drugs during the st...
Occurrence of the main study outcomes and mean follow-up time according to cohort and effectiveness ...
Quantitative sum of number of studies investigating reliability and validity of screening tools.</p
Number of studies found after the visits and initial key word search and after the first screening o...
Overview of number of patients that underwent initial and follow-up screening per year.</p
<p>Enrollment, attrition, drug treatments, and outcomes of patients in all samples.</p
<p>Flowchart of included efficacy trials and additional reports of long-term follow-up assessments.<...
<p>Enrollment, randomization, follow-up, and inclusion in the final analysis in the study comparing ...
Completion status of vaccine series based on year of incident prescription, and number and proportio...
<p>Treatments administered by each study and respective study characteristics for included efficacy ...
Follow-up periods and required doses applied per vaccine for series completion.</p
PrEP uptake and persistence at baseline, 6 months, and 12 months after study enrollment.</p
<p>Cohort enrolment, treatment and follow up and decision making for progression to screening of the...
Analysis of the effects of the interventions on uptake of VMMC three months after enrollment.</p
<p>Description of follow-up time in years for study patients on anti-retroviral therapy (n = 1,282)....
<p>Prescribed amount and number of years of prescription of fall-risk-increasing drugs during the st...
Occurrence of the main study outcomes and mean follow-up time according to cohort and effectiveness ...
Quantitative sum of number of studies investigating reliability and validity of screening tools.</p
Number of studies found after the visits and initial key word search and after the first screening o...